TIGAR and non-small cell lung carcinoma: Recently, the cytotoxic effects of the DNA methyltransferase inhibitor decitabine and the inhibitor of heme-oxygenase tin mesoporphyrin have been linked to decreased expression of TIGAR and reduced PPP in myeloid leukemia and non-small cell lung carcinoma (NSCLC), respectively [10,11].